FIELD: biotechnology.
SUBSTANCE: invention concerns biotechnology and conjugates of hydroxyalkyl starch and protein of factor (G-CSF) stimulating granulocyte colonies. The conjugates are formed by covalent link between hydroxyethyl starch or its derivative with molecular weight within 2 to 200 kD and protein.
EFFECT: methods of conjugate obtainment and application.
26 cl, 7 ex, 2 tbl, 21 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING DERIVATIVES OF HYDROXYALKYL STARCH | 2003 |
|
RU2329274C2 |
| CONJUGATES OF HYDROXYALKYL STARCH AND ALLERGEN | 2003 |
|
RU2325925C2 |
| A CONJUGATE OF HYDROXYALKYL STARCH AND LOW-MOLECULAR SUBSTANCE AND METHOD OF OBTAINING IT | 2003 |
|
RU2327702C2 |
| POLYPEPTIDES TREATED WITH HAS, PARTICULARLY ERYTHROPOIETIN TREATED WITH HAS | 2003 |
|
RU2328505C2 |
| TRANSPORT MEDIATING COLLOIDAL THERAPEUTIC COMPOUNDS | 2009 |
|
RU2519225C2 |
| HYDROXYALKYL STARCH DERIVATIVES | 2003 |
|
RU2326891C2 |
| METHOD OF SYNTHESISING CONJUGATES OF GLYCOSEAMINOGLYCANES (GAG) WITH BIOLOGICALLY ACTIVE MOLECULES, POLYMER CONJUGATES AND THEIR RESPECTIVE APPLICATIONS | 2010 |
|
RU2530649C2 |
| CONJUGATES OF HEMOGLOBIN WITH POLYSACCHARIDE | 1999 |
|
RU2225222C2 |
| GLYCO-PEG GRANULOCYTE COLONY-STIMULATING FACTOR | 2004 |
|
RU2400490C2 |
| NOVEL STABILISER FOR PHARMACEUTICAL PROTEINS | 2011 |
|
RU2571496C2 |
